Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in VCEL — Vericel Corp

CIK 1137774 NEWARK, NJ
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,366,467
+$674,937 QoQ
Shares Held
53,191
+1.2% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#99
of 317 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. VCEL ranks #48 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 130,659 $81,471,112
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 133,294 $66,211,127
3 BMRN
Biomarin Pharmaceutical Inc
 392,811 $22,476,644
4 INCY
Incyte Corp
 191,312 $21,687,128
5 CYTK
Cytokinetics Inc
 214,535 $18,276,236
6 LGND
Ligand Pharmaceuticals Inc
 54,623 $17,265,784
7 PTCT
Ptc Therapeutics, Inc.
 185,820 $15,157,337
8 MRVI
Maravai Lifesciences Holdings, Inc.
 2,152,154 $13,429,440

All Filings in VCEL

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,366,467 53,191
2026-03-31 $1,691,530 52,581
2025-12-31 $1,718,433 47,721
2025-09-30 $1,606,039 51,034
2025-06-30 $2,227,024 52,339
2025-03-31 $2,153,985 48,274
2024-12-31 $2,745,719 50,004
2024-09-30 $2,290,076 54,203
2024-06-30 $2,527,299 55,085
2024-03-31 $2,936,632 56,452
2023-12-31 $2,803,966 78,741
2023-09-30 $3,421,687 102,079
2023-06-30 $3,868,958 102,980
2023-03-31 $1,441,224 49,155
2022-12-31 $1,329,274 50,466
2022-09-30 $1,179,348 50,834
2022-06-30 $1,260,660 50,066
2022-03-31 $1,963,016 51,361
2021-12-31 $1,947,000 49,542
2021-09-30 $3,041,899 62,334
2021-06-30 $2,685,532 51,153
2021-03-31 $2,934,873 52,833